.jpg)
The Latest “Buzz on the Street” Show: Featuring CLS Holdings USA Inc. (OTCQB: $CLSH) at MJBizCon
13 Nov, 2018
The Latest “Buzz on the Street” Show: Featuring WeedMD Inc. (OTCQX: $WDDMF) (TSX-V: $WMD)
FinancialBuzz.com’s latest offering, Buzz on the Street, presents our corporate news recap on “WeedMD and Blockstrain Pilot a Proprietary Genome Tracking Program to Protect Cannabis Genetics & Intellectual Property” and “..
Biogen Reports Positive Results on Alzheimer's Trial, Shares Soar
Biogen Inc. (NASDAQ: BIIB) announced today that the outcome of its large clinical trial consisting of 856 patients regarding an Alzheimer’s drug produced positive results. Together with its Japanese partner, Eisai Co., the experimental dr..
Major Drug Retailers Lose Over USD 12.8 Billion in Value
Shares of CVS (NYSE: CVS), Walgreens (NYSE: WBA) and Rite-Aid (NYSE: RAD) lost USD 12.8 Billion in value after Amazon.com, Inc. (NASDAQ: AMZN) announced that it had signed an agreement to buy the online pharmacy, PillPack, on Thursday.PillPack organ..
Walgreens has joined as the newest member of Dow with the exit of General Electric on Tuesday.
Walgreens Boots Alliance Inc (NASDAQ: WBA) is a giant drug store chain that started in Chicago in 1901, and chances are you've either heard of the brand or shopped at one. The latter part of the company name, Boots Alliance, refers to the c..
Bayer to Get Approval from Justice Department to Acquire Monsanto
According to the person familiar with the matter, Bayer AG, the German drugs and pesticides group, is to get approval from the U.S. Justice Department to acquire Monsanto Company (NYSE: MON) for $62.5 billion.Shares of Monsanto rose 6.5% to $125.47 ..
Sanofi Beats Novo Nordisk for Ablynx Acquisition
French drug maker Sanofi (NYSE: SNY) has entered into an agreement to acquire Ablynx for 3.9 billion euros or 45 euros per share ($4.8 billion), beating Novo Nordisk’s bid. Under the agreement, Sanofi will acquire all outstanding shares, ..
AbbVie Shares Up on Stronger than Expected Q4 Beat
AbbVie Inc. (NYSE: ABBV) reported its fourth quarter financial results for fiscal year 2017. The pharmaceutical company reported better than expected earnings sending shares 13.5 percent before market close on Friday.For the fourth quarter, AbbVie r..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).